(Q44566239)

English

Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

myeloproliferative disorders

1 reference

based on heuristic

author name string

Pascal Trempat

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Claire Villalva

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Guy Laurent

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Florence Armstrong

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Georges Delsol

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Nicole Dastugue

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Pierre Brousset

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

5702-5706

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206543

0 references

Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Low concentrations of STI571 in the cerebrospinal fluid: a case report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206543

21 January 2018

Identifiers

10.1038/SJ.ONC.1206543

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_jqqgdq33nvgmfos7yqiop5mhya

1 reference

https://api.fatcat.wiki/v0/release/jqqgdq33nvgmfos7yqiop5mhya

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44566239&oldid=2028186455"